Literature DB >> 16460549

Risk groups for clinical complications of norovirus infections: an outbreak investigation.

F Mattner1, D Sohr, A Heim, P Gastmeier, H Vennema, M Koopmans.   

Abstract

Norovirus infections have been described as self-limiting diseases of short duration. An investigation of a norovirus outbreak in a university hospital provided evidence for severe clinical features in patients with several underlying diseases. Clinical outcomes of norovirus infection were defined. Risk-factor analysis targeting underlying diseases and medication was performed using multivariate analyses. In five outbreak wards, 84 patients and 60 nurses were infected (an overall attack rate of 32% in patients, and 76% in nurses). The causative agent was the new variant Grimsby virus. Severe clinical features, including acute renal failure, arrhythmia and signs of acute graft organ rejection in renal transplant patients, were observed in seven (8.3%) patients. In multivariate analyses, cardiovascular disease (OR 17.1, 95% CI 2.17-403) and renal transplant (OR 13.0, 95% CI 1.63-281) were risk-factors for a potassium decrease of >20%. Age >65 years (OR 11.6, 95% CI 1.89-224) was a risk-factor for diarrhoea lasting >2 days. Immunosuppression (OR 5.7, 95% CI 1.78-20.1) was a risk-factor for a creatinine increase of >10%. Norovirus infections in patients with underlying conditions such as cardiovascular disease, renal transplant and immunosuppressive therapy may lead to severe consequences typified by decreased potassium levels, increased levels of C-reactive protein and creatine phosphokinase. In the elderly, norovirus infection may lead to an increased duration of diarrhoea. Therefore patients at risk should be hospitalised early and monitored frequently. Strict preventional measures should be implemented as early as possible to minimise the risk of nosocomial outbreaks.

Entities:  

Mesh:

Year:  2006        PMID: 16460549     DOI: 10.1111/j.1469-0691.2005.01299.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  48 in total

1.  Norovirus GII.4 detection in environmental samples from patient rooms during nosocomial outbreaks.

Authors:  Nancy P Nenonen; Charles Hannoun; Lennart Svensson; Kjell Torén; Lars-Magnus Andersson; Johan Westin; Tomas Bergström
Journal:  J Clin Microbiol       Date:  2014-04-23       Impact factor: 5.948

Review 2.  The occurrence and prevention of foodborne disease in vulnerable people.

Authors:  Barbara M Lund; Sarah J O'Brien
Journal:  Foodborne Pathog Dis       Date:  2011-05-11       Impact factor: 3.171

3.  Rapid Responses to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: A Randomized Controlled Trial.

Authors:  Robert L Atmar; Frank Baehner; Jakob P Cramer; Eric Song; Astrid Borkowski; Paul M Mendelman
Journal:  J Infect Dis       Date:  2016-06-28       Impact factor: 5.226

4.  Norovirus in health care and implications for the immunocompromised host.

Authors:  Pearlie P Chong; Robert L Atmar
Journal:  Curr Opin Infect Dis       Date:  2019-08       Impact factor: 4.915

5.  Noroviruses - State of the Art.

Authors:  Robert L Atmar
Journal:  Food Environ Virol       Date:  2010       Impact factor: 2.778

6.  The state of norovirus vaccines.

Authors:  Kari Debbink; Lisa C Lindesmith; Ralph S Baric
Journal:  Clin Infect Dis       Date:  2014-02-27       Impact factor: 9.079

7.  The Prevalence of Norovirus in returning international travelers with diarrhea.

Authors:  Nadja Apelt; Christine Hartberger; Hartmut Campe; Thomas Löscher
Journal:  BMC Infect Dis       Date:  2010-05-25       Impact factor: 3.090

8.  New real-time PCR detects prolonged norovirus excretion in highly immunosuppressed patients and children.

Authors:  C Henke-Gendo; G Harste; B Juergens-Saathoff; F Mattner; H Deppe; A Heim
Journal:  J Clin Microbiol       Date:  2009-07-22       Impact factor: 5.948

Review 9.  Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations.

Authors:  Negar Aliabadi; Ben A Lopman; Umesh D Parashar; Aron J Hall
Journal:  Expert Rev Vaccines       Date:  2015-07-29       Impact factor: 5.217

10.  Fecal viral concentration and diarrhea in norovirus gastroenteritis.

Authors:  Nelson Lee; Martin C W Chan; Bonnie Wong; K W Choi; Winnie Sin; Grace Lui; Paul K S Chan; Raymond W M Lai; C S Cockram; Joseph J Y Sung; Wai K Leung
Journal:  Emerg Infect Dis       Date:  2007-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.